201 related articles for article (PubMed ID: 24147470)
21. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
23. Added value of diffusion-weighted MR imaging in the diagnosis of ampullary carcinoma.
Jang KM; Kim SH; Lee SJ; Park HJ; Choi D; Hwang J
Radiology; 2013 Feb; 266(2):491-501. PubMed ID: 23238154
[TBL] [Abstract][Full Text] [Related]
24. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of diffusion-weighted MR imaging for differentiating between benign and malignant superficial soft tissue tumours and tumour-like lesions.
Jeon JY; Chung HW; Lee MH; Lee SH; Shin MJ
Br J Radiol; 2016; 89(1060):20150929. PubMed ID: 26892266
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma.
Hur BY; Lee JM; Lee JE; Park JY; Kim SJ; Joo I; Shin CI; Baek JH; Kim JH; Han JK; Choi BI
J Magn Reson Imaging; 2012 Jul; 36(1):188-97. PubMed ID: 22371378
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
[TBL] [Abstract][Full Text] [Related]
28. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
29. Role of apparent diffusion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules.
Mutlu H; Sivrioglu AK; Sonmez G; Velioglu M; Sildiroglu HO; Basekim CC; Kizilkaya E
Clin Imaging; 2012; 36(1):1-7. PubMed ID: 22226435
[TBL] [Abstract][Full Text] [Related]
30. Diffusion-weighted MRI of the pancreas: correlation with secretin endoscopic pancreatic function test (ePFT).
Balci NC; Momtahen AJ; Akduman EI; Alkaade S; Bilgin M; Burton FR
Acad Radiol; 2008 Oct; 15(10):1264-8. PubMed ID: 18790398
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map.
Rosenkrantz AB; Kong X; Niver BE; Berkman DS; Melamed J; Babb JS; Taneja SS
AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of diffusion-weighted imaging in the evaluation of renal masses.
Sandrasegaran K; Sundaram CP; Ramaswamy R; Akisik FM; Rydberg MP; Lin C; Aisen AM
AJR Am J Roentgenol; 2010 Feb; 194(2):438-45. PubMed ID: 20093607
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted imaging in characterization of cystic pancreatic lesions.
Sandrasegaran K; Akisik FM; Patel AA; Rydberg M; Cramer HM; Agaram NP; Schmidt CM
Clin Radiol; 2011 Sep; 66(9):808-14. PubMed ID: 21601184
[TBL] [Abstract][Full Text] [Related]
36. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
37. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI.
Kim JK; Altun E; Elias J; Pamuklar E; Rivero H; Semelka RC
J Magn Reson Imaging; 2007 Aug; 26(2):313-22. PubMed ID: 17610286
[TBL] [Abstract][Full Text] [Related]
38. Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging.
Zhang TT; Wang L; Liu HH; Zhang CY; Li XM; Lu JP; Wang DB
Oncotarget; 2017 Jan; 8(1):1744-1759. PubMed ID: 27661003
[TBL] [Abstract][Full Text] [Related]
39. MR imaging features of small solid pseudopapillary tumors: retrospective differentiation from other small solid pancreatic tumors.
Yu MH; Lee JY; Kim MA; Kim SH; Lee JM; Han JK; Choi BI
AJR Am J Roentgenol; 2010 Dec; 195(6):1324-32. PubMed ID: 21098190
[TBL] [Abstract][Full Text] [Related]
40. Quantified ADC histogram analysis: a new method for differentiating mass-forming focal pancreatitis from pancreatic cancer.
Ma X; Zhao X; Ouyang H; Sun F; Zhang H; Zhou C
Acta Radiol; 2014 Sep; 55(7):785-92. PubMed ID: 24167322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
